Coffee consumption and reduced risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study
- PMID: 21258859
- PMCID: PMC3400401
- DOI: 10.1007/s10552-010-9725-0
Coffee consumption and reduced risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study
Abstract
Background: Coffee consumption has been associated with reduced markers of hepatic cell damage, reduced risk of chronic liver disease, and cirrhosis across a variety of populations. Data on the association between coffee consumption and risk of hepatocellular carcinoma (HCC), especially in high-risk populations, are sparse.
Methods: This study examines the relationship between coffee and caffeine consumption, and the risk of developing HCC within the Singapore Chinese Health Study, a prospective cohort of 63,257 middle-aged and older Chinese men and women, a relatively high-risk population for HCC. Baseline data on coffee consumption and other dietary and lifestyle factors were collected through in-person interviews at enrollment between 1993 and 1998.
Results: As of 31 December 2006, 362 cohort participants had developed HCC. High levels of coffee or caffeine consumption were associated with reduced risk of HCC (p for trend < 0.05). Compared with non-drinkers of coffee, individuals who consumed three or more cups of coffee per day experienced a statistically significant 44% reduction in risk of HCC (hazard ratio 0.56, 95% confidence interval, 0.31-1.00, p = .049) after adjustment for potential confounders and tea consumption.
Conclusion: These data suggest that coffee consumption may reduce the risk of developing HCC in Chinese in Singapore.
References
-
- Ferlay J, et al. IARC cancerbase No. 5 version 2.0. International Agency for Research of Cancer; Lyon: 2004. GLOBOCAN 2002: cancer incidence, mortality, and prevalence worldwide.
-
- Yu MC, Yuan JM. Environmental factors and risk for hepatocellular carcinoma. Gastroenterology. 2004;127(5 Suppl 1):S72–S78. - PubMed
-
- Azam S, et al. Antioxidant and prooxidant properties of caffeine, theobromine and xanthine. Med Sci Monit. 2003;9(9):BR325–BR330. - PubMed
-
- Okano J, et al. Caffeine inhibits the proliferation of liver cancer cells and activates the MEK/ERK/EGFR signalling path-way. Basic Clin Pharmacol Toxicol. 2008;102(6):543–551. - PubMed
-
- Hosaka S, et al. Hepatocarcinogenesis inhibition by caffeine in ACI rats treated with 2-acetylaminofluorene. Food Chem Toxicol. 2001;39(6):557–561. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
